These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7860418)

  • 41. Effect of inhibition of increased gonadotrophin secretion before 20 weeks of age in bull calves on testicular development.
    Chandolia RK; Evans AC; Rawlings NC
    J Reprod Fertil; 1997 Jan; 109(1):65-71. PubMed ID: 9068415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.
    Okada H; Heya T; Ogawa Y; Shimamoto T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):744-50. PubMed ID: 3126294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocrinological studies on TAP-144-SR, a sustained-release formulation of a potent GnRH agonist (D-Leu6-[des-Gly10-NH2]-GnRH ethylamide), in male rats.
    Sudo K; Masaki T; Shiota K; Kawase M; Fujita T
    Endocrinol Jpn; 1990 Oct; 37(5):685-93. PubMed ID: 2128273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
    Bayhan G; Bahçeci M; Demirkol T; Ertem M; Yalinkaya A; Erden AC
    Clin Exp Obstet Gynecol; 2000; 27(3-4):203-6. PubMed ID: 11214952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testicular modulation of luteinizing hormone response to gonadotropin-releasing hormone (GnRH)-agonist treatment.
    Bhasin S; Fielder TJ; Sod-Moriah UA; Swerdloff RS
    Biol Reprod; 1987 Mar; 36(2):309-13. PubMed ID: 2883996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of the gonadotropin-releasing hormone agonist buserelin after injection of a slow-release preparation in normal men.
    Behre HM; Sandow J; Nieschlag E
    Arzneimittelforschung; 1992 Jan; 42(1):80-4. PubMed ID: 1586387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the impact of concurrent gonadotropin-releasing hormone (GnRH) antagonist administration on GnRH agonist-induced gonadotrope desensitization.
    Illions EH; Scott RT; Carey KD; Navot D
    Fertil Steril; 1995 Oct; 64(4):848-54. PubMed ID: 7672160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effect of Longer-Acting vs Shorter-Acting Testosterone Therapy on Follicle Stimulating Hormone and Luteinizing Hormone.
    Masterson TA; Turner D; Vo D; Blachman-Braun R; Best JC; Westfield G; Bryson N; Ramasamy R
    Sex Med Rev; 2021 Jan; 9(1):143-148. PubMed ID: 32912767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.
    Reznik Y; Chapon F; Lahlou N; Deboucher N; Mahoudeau J
    J Endocrinol Invest; 1997 Oct; 20(9):566-8. PubMed ID: 9413812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range.
    Buena F; Swerdloff RS; Steiner BS; Lutchmansingh P; Peterson MA; Pandian MR; Galmarini M; Bhasin S
    Fertil Steril; 1993 May; 59(5):1118-23. PubMed ID: 8486184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamics of a long acting depot preparation of avorelin in patients with prostate cancer. Avorelin Study Group.
    Kaisary AV; Bowsher WG; Gillatt DA; Anderson JB; Malone PR; Imbimbo BP
    J Urol; 1999 Dec; 162(6):2019-23. PubMed ID: 10569560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating gonadotropin pattern in anorchia syndrome. Response to treatment.
    Mendoza-Morfin F; Rodríguez-López M; Oliveros-Rodríguez A; Altamirano-Bustamante P; Navarrete-López R; Gutiérrez-Pérez H; Oseguera-Valladares R
    Arch Invest Med (Mex); 1980; 11(2):239-47. PubMed ID: 6775612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testosterone modulation of anxiety in gonadally-suppressed male rhesus monkeys: a role for gonadotropins?
    Suarez-Jimenez B; Gore HE; Hachey J; King HM; Lacreuse A
    Pharmacol Biochem Behav; 2013 Mar; 104():97-104. PubMed ID: 23333155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term suppression of luteinizing hormone, follicle-stimulating hormone and testosterone by daily administration of leuprolide.
    Glode LM; Smith JA
    J Urol; 1987 Jan; 137(1):57-60. PubMed ID: 3098990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FSH Is Responsible for Androgen Deprivation Therapy-Associated Atherosclerosis in Mice by Exaggerating Endothelial Inflammation and Monocyte Adhesion.
    Wang Q; Han J; Liang Z; Geng X; Du Y; Zhou J; Yao W; Xu T
    Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):698-719. PubMed ID: 38205641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of epitopes on follicle-stimulating hormone and FSH-antiserum-induced suppression of bioactivity of follicle-stimulating hormone and luteinizing hormone.
    Westhoff WE; Slootstra JW; Puijk WC; Kuperus D; Flinterman JF; Schaaper WM; Oonk HB; Meloen RH
    J Reprod Immunol; 1996 May; 30(2-3):133-49. PubMed ID: 8816329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [An XY eunuchism syndrome with preserved spermatogenesis and normal secretion of FSH, ICSH and testosterone. Preliminary report].
    Del Pozo E
    Rev Iber Endocrinol; 1969; 16(95):393-6. PubMed ID: 5408621
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of TAP-144-SR, a sustained-release formulation of a potent GnRH agonist, on experimental endometriosis in the rat.
    Sudo K; Shiota K; Masaki T; Fujita T
    Endocrinol Jpn; 1991 Feb; 38(1):39-45. PubMed ID: 1915112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical evaluation of the prognostic value of GnRH-test in oligospermic patients with basal levels of FSH and T in the normal range: part two.
    Scarselli G; Noci I; Melotti D; Chelo E; Pupi A; Tantini C
    Acta Eur Fertil; 1981 Jun; 12(2):197-8. PubMed ID: 6794289
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of early postnatal treatment with a gonadotropin-releasing hormone agonist on the developmental profiles of testicular steroid hormones in the intact male pig.
    Sinclair PA; Squires EJ; Raeside JI; Britt JH; Hedgpeth VG
    J Anim Sci; 2001 Apr; 79(4):1003-10. PubMed ID: 11325174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.